Adapthealth Corp SEC Filings

SEC Form 4 filed on 06/30/2025 shows AdaptHealth Corp. (AHCO) director Gregory Belinfanti acquired a total of 28,086 common shares on 06/26/2025 through two transactions recorded at $0.00 per share, indicating stock awards rather than open-market purchases. His direct holdings rose from an estimated 45,408 shares to 73,494 shares after the grants. No derivative securities were reported. While the amount is modest relative to AHCO’s float, the additional ownership slightly tightens insider–shareholder alignment and is typically viewed as a mildly positive governance signal.

AdaptHealth Corp. (AHCO) filed a Form 4 reporting an insider equity transaction by director Dale B. Wolf. On 26 June 2025, Wolf acquired 21,346 shares of common stock at a stated price of $0.00, a typical indicator of a stock award or equity grant rather than an open-market purchase. Following the award, his direct holdings rose to 96,235 shares, up roughly 28% from the prior 74,889-share position. In addition, Wolf continues to hold 14,000 shares indirectly through the Dale B. Wolf Generation Skipping Trust, for which he serves as investment manager.

No shares were sold and no derivative securities were exercised. The filing therefore represents a modest, non-cash increase in insider ownership and adds limited incremental dilution to AdaptHealth’s share count. While insider grants do not carry the same signaling power as open-market purchases, they can still improve alignment between the director and outside shareholders, especially when the shares are retained rather than immediately sold. Investors may view the award as a neutral-to-slightly-positive governance development; however, its dollar value appears immaterial relative to the company’s market capitalization and is unlikely to have a meaningful impact on valuation or liquidity.

Form 4 filing for AdaptHealth Corp. (AHCO) reports that director David S. Williams III acquired 21,346 shares of common stock on 06/26/2025 at a stated price of $0.00 per share, suggesting the shares were received through an equity award or similar non-cash grant. Following the transaction, Williams now beneficially owns 58,245 shares, all held directly. No derivative securities or dispositions were disclosed, and the filing was signed on 06/30/2025 by an attorney-in-fact.

• Reporting person status: Director, single filer
• Transaction code: “A” (acquisition)
• Ownership form: Direct
• No sales, derivative activity, or 10b5-1 plan indicated

AdaptHealth Corp. (AHCO) – Form 4 filing overview:

• Reporting person: Diana L. Nole, listed as a Director of AdaptHealth Corp.
• Transaction date: 06/26/2025.
• Security: Common Stock.
• Transaction type & size: Acquisition of 21,346 shares (code “A”) at a reported price of $0 per share.
• Post-transaction holdings: 33,045 shares held directly.
• Form signing date: 06/30/2025, executed by attorney-in-fact Richard Rew.

No derivative securities were reported and no sales were disclosed. The filing reflects an increase in insider ownership, which may be interpreted by some investors as a sign of board-level confidence, although the dollar value and context of the grant are not provided in the document.

AdaptHealth Corp. (AHCO) filed a Form 4 reporting that director Bradley J. Coppens acquired 21,346 shares of common stock on 06/26/2025. The shares were recorded at a stated price of $0.00, indicating a grant or other non-cash issuance. Following the transaction, Coppens’ direct ownership stands at 77,346 AHCO shares. No derivative securities were reported, and no other officers or insiders were listed on this filing.

AdaptHealth Corp (AHCO) filed a Form 3 Initial Statement of Beneficial Ownership for Daniel Edward McFadden, who has been appointed as the company's Chief Business Systems Officer. The filing, dated June 28, 2025, discloses McFadden's initial beneficial ownership position in the company.

Key ownership details:

• McFadden beneficially owns 53,958 shares of common stock in the form of restricted stock units (RSUs)
• The ownership is held directly (D)
• The RSUs will be settled in common stock upon vesting

The filing was executed by Richard Rew as attorney-in-fact for Daniel McFadden on June 26, 2025. This Form 3 filing is required under Section 16(a) of the Securities Exchange Act of 1934 for new officers, directors, or beneficial owners of more than 10% of a company's securities.